| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| BUY | BUY | BUY | BUY | BUY |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 3.03▲ | 3.02▲ | 3.02▲ | 2.97▲ | 2.78▲ |
| MA10 | 3.02▲ | 3.02▲ | 3.02▲ | 2.81▲ | 2.50▲ |
| MA20 | 3.02▲ | 3.02▲ | 3.03▲ | 2.70▲ | 2.66▲ |
| MA50 | 3.01▲ | 3.03▲ | 2.88▲ | 2.43▲ | 3.01▲ |
| MA100 | 3.02▲ | 2.87▲ | 2.75▲ | 2.66▲ | 3.68▼ |
| MA200 | 3.03▲ | 2.75▲ | 2.60▲ | 2.84▲ | 2.77▲ |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | 0.003▲ | -0.001▼ | -0.012▼ | 0.041▲ | 0.099▲ |
| RSI | 70.735▲ | 57.478▲ | 58.602▲ | 69.665▲ | 56.674▲ |
| STOCH | 77.778 | 74.591 | 55.312 | 65.953 | 72.364 |
| WILL %R | 0.000▲ | -10.000▲ | -43.750 | -27.059 | -16.547▲ |
| CCI | 294.097▲ | 117.117▲ | 31.323 | 114.170▲ | 146.782▲ |
|
Friday, August 15, 2025 12:09 PM
Savara (SVRA) stock was upgraded to Buy at H.C. Wainwright, citing higher prospects for a resubmitted marketing application for lead asset Molbreevi. Read more here.
|
|
Wednesday, August 13, 2025 12:05 AM
Savara Inc. (Nasdaq: SVRA) (the Company), a clinical stage biopharmaceutical company focused on rare respiratory diseases, reported financial results for the second quarter ending June 30, 2025 and ...
|
|
Thursday, July 31, 2025 08:57 PM
Savara Inc. (NASDAQ:SVRA) is one of the best biotech penny stocks to buy right now. On June 2, Oppenheimer assumed coverage of Savara Inc. (NASDAQ:SVRA) with an Outperform rating, bringing the ...
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 19/08/25 | 3.03 | 3.05 | 2.96 | 3.05 | 560,345 |
| 18/08/25 | 3.06 | 3.125 | 3.0111 | 3.05 | 1,113,325 |
| 15/08/25 | 3.28 | 3.28 | 2.96 | 3.04 | 1,718,726 |
| 14/08/25 | 2.70 | 3.095 | 2.68 | 3.01 | 3,469,622 |
| 13/08/25 | 2.53 | 2.84 | 2.43 | 2.70 | 1,802,105 |
| 12/08/25 | 2.74 | 2.79 | 2.55 | 2.58 | 1,711,244 |
| 11/08/25 | 2.64 | 2.73 | 2.64 | 2.70 | 447,561 |
| 08/08/25 | 2.64 | 2.705 | 2.595 | 2.64 | 433,996 |
| 07/08/25 | 2.74 | 2.765 | 2.565 | 2.63 | 485,978 |
| 06/08/25 | 2.69 | 2.755 | 2.60 | 2.74 | 395,564 |
|
|
||||
|
|
||||
|
|